Home > List All Publishers > Urch Publishing

Urch Publishing

Urch Publishing is a UK-based business information provider dedicated to providing pharmaceutical industry executives the information they need in their jobs. All publications and information products are carefully researched by experts and written in a clear and succinct style.
Busy executives can rely on Urch Publishing to make their life easier as Urch has committed itself to 3 simple principles.
1. Quality
Urch prides itself on always offering quality products, directly relevant to your business. All publications are based on expert analysis, informed opinion and both primary and secondary research.

2. Understanding
Urch realizes that all executives are time-poor and under considerable pressure. All publications are all designed to save time by identifying the information you need in your job.
3. Customer Service
Although most Urch customers are from large organizations, we realize that it is individuals who make up these companies and chose to buy our products. We strive to offer our customers the best possible service by ensuring our customer service staff fulfill your order as quickly as possible and can answer any question you may have.

List of reports from Urch Publishing

Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations 4/1/2003 \| published by: Urch Publishing ... costs, government regulations, and stringent manufacturing requirements. Thus, all biopharmaceutical companies are under the competing pressures of innovating, increasing growth and accelerating time-to-market while maintaining product quality. Urch Publishing offers a unique report on this ... \| more... Search inside this report	$990.00
The Pharmaceutical Pricing Compendium - A Practical Guide To The Pricing And Reimbursement Of Medicines 3/1/2003 \| published by: Urch Publishing ... for a company's profitability. The Pharmaceutical Pricing Compendium - A practical guide to the pricing and reimbursement of medicines provides the essential insight into the business, economic, legal, political and strategic issues that companies must ... \| more... Search inside this report	$225.00
Health Economics in the Drug Life Cycle: Achieving success in drug discovery, development, reimbursement and marketing 1/1/2003 \| published by: Urch Publishing ... early stage in the drug development process. If correctly applied, health economics techniques will deliver a product unit price which creates a win-win situation between the manufacturer and the purchaser or prescriber of the drug, ... \| more... Buy by the section \| Search inside this report	$1,251.00
European Generic Drug Markets - Growth to 2007 11/1/2002 \| published by: Urch Publishing ... pressures on healthcare services and organisations will lead to increased adoption of generic substitution and prescribing practices in many EU Member States boosting volume and value for the industry. Other factors such as patent expiry ... \| more... Buy by the section \| Search inside this report	$891.00
The Pharmaceutical Pricing and Reimbursement Systems of Central and Eastern Europe 6/24/2002 \| published by: Urch Publishing ... Pharmaceutical pricing and reimbursement is a complex and ever-changing area. In a rapidly globalising market it is essential that you are briefed on the regulatory systems that determine the way in which your company operates ... \| more... Buy by the section \| Search inside this report	$560.00
Emerging Pharmaceutical Markets - Potential & Problems 10/26/2001 \| published by: Urch Publishing ... drug development and approval in the three regions, thus providing patients with more timely access to new medicines. The current major focus of ICH is development of a Common Technical Document that would form the ... \| more... Buy by the section \| Search inside this report	$351.00
Customer-Driven Pharmaceutical Marketing: developing and exploiting profitable relationships 3/30/2001 \| published by: Urch Publishing ... by pharmaceutical management with decreasingly satisfying results. Mergers and acquisitions are being consummated with only short-term, ad hoc, quick fix results. Traditional schools of strategic thinking offer a number of perspectives on how to compete. \| more... Buy by the section \| Search inside this report	$225.00
Good Laboratory And Good Clinical Practice: Requirements For Compliance - Management Involvement And Cost Implications 3/1/2001 \| published by: Urch Publishing ... even more important to ensure that studies are correctly carried out and in compliance with the regulations. This definitive new guide sets out to review the Good Laboratory and Good Clinical Practice compliance guidelines and ... \| more...	$72.00
Drug Discovery: Current Trends and Future Prospects 2/1/2001 \| published by: Urch Publishing ... numbers of compounds used in screening against biological targets, and technologies for target validation (antisense, gene knockout, functional genetic screens, gene expression arrays and proteomic approaches). Learn how new drug targets are identified, and the ... \| more... Buy by the section \| Search inside this report	$560.00
A Healthy Business Guide to the Pharmaceutical Industry 1/1/2001 \| published by: Urch Publishing ... R&D stages through to clinical trials, launch, post marketing and product life-cycle. The author examines how companies are built, what has been successful, future growth area and where the industry is headed as a whole. \| more...	$81.00
New Trends In European Pharmacy 1/1/2001 \| published by: Urch Publishing ... are subject to fundamental changes; consequently its methods, limitations and opportunities are adapting. This report analyses the development of pharmacy systems in Europe; in the 15 member states of the European Union (EU), the EU-applicant ... \| more... Buy by the section \| Search inside this report	$360.00
Trends in the Plastics Industry 10/1/2000 \| published by: Urch Publishing ... methods of production and processes of monomers like styrene, vinyl chloride, methyl methacrylate and caprolactam and reviews the potential of these materials to reduce the cost of production and create synergy savings and capacity increases. \| more...	$630.00
EU Accession by Central and Eastern European Countries: Issues for Researched-Based Pharmaceutical Companies 10/1/2000 \| published by: Urch Publishing European Union enlargement to the east brings both threats and opportunities to multinational pharmaceutical companies. This report documents the changes in this sector that will affect all companies. \| more... Buy by the section \| Search inside this report	$306.00
The Billion Dollar Pharmaceutical Club: Profiles of the Leading European Players 9/1/2000 \| published by: Urch Publishing ... reviewing financial and market share data. The profiles provide analyses of corporate structure and development; geographic organisation; pharmaceutical portfolio by therapy area, highlighting leading products sales and trends; major commercial collaborations; R&D alliances, strategies and ... \| more...	$178.20
The Billion Dollar Pharmaceutical Club: Profiles of the Leading US Players 8/1/2000 \| published by: Urch Publishing ... reviewing financial and market share data. The profiles provide analyses of corporate structure and development; geographic organisation; pharmaceutical portfolio by therapy area, highlighting leading products sales and trends; major commercial collaborations; R&D alliances, strategies and ... \| more...	$178.20
Cost Containment in Healthcare: Putting the Pharmaceutical Industry in Perspective 8/1/2000 \| published by: Urch Publishing ... actions policy-makers, providers and payers have taken to tackle the healthcare problems associtated with an ageing population, rising patient expectations, system inefficiencies, high costs of new drugs and treatments and keeping up with technology developments. \| more... Buy by the section \| Search inside this report	$178.20
The Billion Dollar Pharmaceutical Club: Profiles of the Leading Japanese Players 8/1/2000 \| published by: Urch Publishing ... reviewing financial and market share data. The profiles provide analyses of corporate structure and development; geographic organisation; pharmaceutical portfolio by therapy area, highlighting leading products sales and trends; major commercial collaborations; R&D alliances, strategies and ... \| more...	$178.20
China Pharmaceuticals Guide: New Policy and Regulation 6/1/2000 \| published by: Urch Publishing ... Concept Consulting, the Chinese Information Centre of The State Drug Administration (SDA) and Informa Pharmaceuticals have prepared the China Pharmaceuticals Guide - a definitive reference manual to the regulation of pharmaceuticals in this exciting market. \| more... Buy by the section \| Search inside this report	$360.00
WTO and Patents -- The Impact on the Pharmaceutical Industry 5/1/2000 \| published by: Urch Publishing ... the importance of the TRIPS framework as a step toward globalisation of legal requirements and reviews the role of the WTO. Jargon-free, this publication will guide you through the most fundamental aspects of the industry. \| more... Buy by the section \| Search inside this report	$315.00
Pharmaceutical Regulation in Europe: An Industry Challenge 4/1/2000 \| published by: Urch Publishing ... field. Starting with the very first Community legislation on public health and medicines, the report guides you right through to the current day where the Commission's influence pervades almost every aspect of the pharmaceutical industry. \| more... Buy by the section \| Search inside this report	$270.00
Mergers and Acquisitions in the Chemical Industry 3/1/2000 \| published by: Urch Publishing ... are a significant number of major deals in the pipeline moving towards completion and much unfinished business. This report examines the factors causing M&A activity and analyses all the recent deals plus deals in progress ... \| more...	$900.00
Mergers and Acquisitions in Pharmaceuticals -- Why and How? 2/1/2000 \| published by: Urch Publishing ... of high margins and large-scale price premiums for innovative high tech acquisitions through to the increasing speed to acquire novel new drugs in the 21st century in a bid to reduce R&D and production costs. \| more... Buy by the section \| Search inside this report	$270.00
Patient Groups and the Global Pharmaceutical Industry 1/1/2000 \| published by: Urch Publishing ... changing dynamics taking place within the pharmaceutical industry world-wide and documents the rise of the patient (consumer) as a potent economic force in healthcare and a prime target for sustained competitive advantage for drug companies. \| more... Buy by the section \| Search inside this report	$360.00
Successful Licensing -- Negotiating and Drafting Optimal Pharmaceutical Deals 4/1/1999 \| published by: Urch Publishing ... crucial partnerships. It shows you how to evaluate the uniqueness of an opportunity, together with key aspects involved in the negotiation, the development scope of a partnership and the financial returns involved in any venture. \| more... Search inside this report	$675.00
Oligonucleotide Players 4/1/1999 \| published by: Urch Publishing ... for targeting a wide range of diseases at genetic level. In this rapidly expanding market, the race is on to develop oligonucleotide drugs for the treatment of diseases such as Cancer, HIV, Hepatitis B and ... \| more... Search inside this report	$590.00

< prev 1 2 next >